Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-12-12 1:40 pm Sale | 2025-12-10 | 13D | CUREVAC N V CUREVAC N V IN CON CVAC | KfW | 0 0.000% | -112,841,355 (Position Closed) | Filing History |
| 2025-08-01 7:10 pm Sale | 2025-08-01 | 13D | CUREVAC N V CUREVAC N V IN CON CVAC | KfW | 112,841,355 50.100% | -1,348,691 (-1.18%) | Filing History |
| 2024-10-07 4:47 pm Sale | 2024-09-30 | 13G | MAINZ BIOMED N V SHS USD MYNZ | KfW | 23 4.400% | -30,915 (-99.93%) | Filing History |
| 2024-02-13 2:39 pm Unchanged | 2023-12-31 | 13G | MAINZ BIOMED N V SHS USD MYNZ | KfW | 30,938 6.400% | 0 (Unchanged) | Filing History |
| 2023-03-01 06:38 am Purchase | 2022-12-31 | 13G | MAINZ BIOMED N V SHS USD MYNZ | KfW | 30,938 8.500% | 30,938 (New Position) | Filing History |
| 2023-02-24 2:35 pm Sale | 2023-02-23 | 13D | CUREVAC N V CUREVAC N V IN CON CVAC | KfW | 114,190,046 51.440% | -1,411,919 (-1.22%) | Filing History |
| 2023-02-13 11:41 am Unchanged | 2023-02-10 | 13D | CUREVAC N V CUREVAC N V IN CON CVAC | KfW | 115,601,965 52.080% | 0 (Unchanged) | Filing History |
| 2022-01-13 4:19 pm Unchanged | 2022-01-13 | 13D | CUREVAC N V CUREVAC N V IN CON CVAC | KfW | 115,601,965 61.800% | 0 (Unchanged) | Filing History |
| 2021-10-18 5:28 pm Sale | 2021-10-15 | 13D | CUREVAC N V CUREVAC N V IN CON CVAC | KfW | 115,601,965 61.900% | -1,788,443 (-1.52%) | Filing History |